Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 · Journal of Clinical Oncology · 2,602 citations
https://doi.org/10.1200/jco.2011.38.8595
M
Manfred Kaufmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
229
Papers
22.2K
Citations
64
h-index
129
i10-index
Manfred Kaufmann is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Estrogen and related hormone effects. The author has an h-index of 64, co-authored 195 publications.
Papers by this author
worksNeoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study
2010 · Journal of Clinical Oncology · 550 citations
https://doi.org/10.1200/jco.2009.23.8451
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
2009 · Breast Cancer Research · 480 citations
https://doi.org/10.1186/bcr2234
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial
2012 · The Lancet Oncology · 453 citations
https://doi.org/10.1016/s1470-2045(11)70397-7
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
2013 · Journal of Clinical Oncology · 419 citations
https://doi.org/10.1200/jco.2012.45.0940
Capecitabine in Addition to Anthracycline- and Taxane-Based Neoadjuvant Treatment in Patients With Primary Breast Cancer: Phase III GeparQuattro Study
2010 · Journal of Clinical Oncology · 229 citations
https://doi.org/10.1200/jco.2009.23.8303
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat